Meet Our Supporters

Osteoporosis and Bone Metastasis in Oncology: Addressing Bone Health Treatment Gaps and the Role of Biosimilars

This session will examine the current strategies and challenges in preventing fractures from osteoporosis and skeletal related events from bone metastasis in patients living with cancer.  It will highlight the clinical and economic burden of bone complications and explore the potential of biosimilars to increase access and reduce healthcare costs.    

Session sponsored by Sandoz. 

Session Chair: Dr Nicole Kuderer 

Session Speakers: 

Dr Matti Aapro – Bone health in cancer: current strategies and challenges

Dr Gary Layman – Clinical and economic burden of skeletal complications

Darrell Wilson – The patient’s perspective on management and care

Best practices in antiemetic control

This symposium, “Best practices in antiemetic control,” will provide an in-depth look at current and emerging strategies to
manage chemotherapy-induced nausea and vomiting. Expert-led discussions will focus on the latest guidelines, evidence, and innovative treatment options to improve patient outcomes in oncology.

This educational activity is supported by an educational grant from Helsinn Healthcare SA.

Session Chairs: Dr Matti Aapro & Prof Florian Scotté

Session Speakers:

Dr Matti Aapro – Vomiting beyond day 5: the science explaining why some drugs may have an advantage

Prof Alex Molasiotis – Nausea: an unsolved issue. Tips to help patients

Advancing Nutritional Care in Oncology: Precision and Multidisciplinary Approaches 

The symposium addresses the critical role of nutritional care in oncology, highlighting targeted nutrition interventions and the importance of a multidisciplinary approach. The session will cover the assessment of body composition, energy metabolism, and the collaborative strategies that enhance patient outcomes in cancer care. 

Session sponsored by Nestlé Health Science. 

Session Chair: Dr Florian Scotté

Session Speakers: 

Dr Carla Prado – Targeted Nutrition in Oncology: Improving Patient Outcomes Through Nutritional Assessment and Intervention 

Dr Florian Scotté – Integrative Oncological Nutrition: A Multidisciplinary Approach

HER2gether: Multidisciplinary Management of Adverse Events in Patients with HER2-expressing Metastatic Breast Cancer

This session will review the importance of using the most efficacious treatment first for HER2-expressing metastatic breast cancer, discuss multidisciplinary management of common adverse events, and educate on best practices to help monitor and manage ILD

Session supported by Daiichi Sankyo Inc. / AstraZeneca.

Session Chair: Dr Maryam Lustberg

Session Speakers: 

Dr Niharika Dixit – Patient Focused Treatment Decision Making in HER2-low, HER2-ultralow, and HER2-null Metastatic Breast Cancer

Dr Maryam Lustberg – Mitigating Common Adverse Events in Patients with HER2-expressing Metastatic Breast Cancer

Dr Niharika Dixit – The Importance of Proactive Monitoring and Management of ILD

Ms. Eva Schumacher-Wulf – Exploring the Patient Experience with Metastatic Breast Cancer

Multidisciplinary Management of Cancer-Related Skin Side Effects

Multidisciplinary management of cancer-related skin side effects requires a collaborative approach involving oncologists, dermatologists, and other specialists to address skin toxicities, rash, itching, and other skin problems, ensuring optimal patient care and treatment outcomes.

Session sponsored by La Roche-Posay.

Session Chair: Prof Florian Scotté

Session Speakers: 

Dr VK Gadi – Examining Dermatologic Adverse Events from Anticancer Therapies

Dr Sanjay Juneja – Dermatological Approach to Management of skin side effects

Dr Sanjay Juneja – Integrated Multidisciplinary Approach